Summit Therapeutics Inc. (SMMT)
NASDAQ: SMMT · Real-Time Price · USD
19.68
+0.85 (4.51%)
At close: Jan 9, 2026, 4:00 PM EST
19.50
-0.18 (-0.91%)
After-hours: Jan 9, 2026, 7:33 PM EST
Summit Therapeutics Market Cap
Summit Therapeutics has a market cap or net worth of $15.18 billion as of January 9, 2026. Its market cap has increased by 10.23% in one year.
Market Cap
15.18B
Enterprise Value
14.94B
1-Year Change
10.23%
Ranking
Category
Stock Price
$19.68
Market Cap Chart
Since March 5, 2015, Summit Therapeutics's market cap has increased from $119.00M to $15.18B, an increase of 12,653.14%. That is a compound annual growth rate of 56.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 14.65B | 12.52% |
| Dec 31, 2025 | 13.02B | -1.06% |
| Dec 31, 2024 | 13.16B | 619.43% |
| Dec 29, 2023 | 1.83B | 113.79% |
| Dec 30, 2022 | 855.60M | 225.45% |
| Dec 31, 2021 | 262.90M | -32.00% |
| Dec 31, 2020 | 386.60M | 653.61% |
| Dec 31, 2019 | 51.30M | 203.55% |
| Dec 31, 2018 | 16.90M | -87.66% |
| Dec 29, 2017 | 137.00M | 30.60% |
| Dec 30, 2016 | 104.90M | -21.83% |
| Dec 31, 2015 | 134.20M | 12.77% |
| Mar 5, 2015 | 119.00M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 990.76B |
| Johnson & Johnson | 499.76B |
| AbbVie | 410.24B |
| UnitedHealth Group | 310.06B |
| AstraZeneca | 293.89B |
| Merck & Co. | 269.93B |
| Novartis AG | 268.87B |
| Novo Nordisk | 254.60B |